Urinary Tract and Genitourinary Cytopathology
Urinary tract and genitourinary cytopathology is the subdivision of cytopathology that evaluates exfoliated and instrumented epithelial cells from the urinary tract — voided urine, bladder washings, catheterised specimens, and brushings of the upper tract — to detect and grade urothelial neoplasia and to characterise benign and reactive changes. Its central clinical purpose is the detection of high-grade urothelial carcinoma, for which urine cytology is highly specific.
Definition
Urinary cytopathology is the microscopic examination of cells shed into or sampled from the urinary tract to identify malignant, atypical, and benign processes, with primary emphasis on the detection of high-grade urothelial carcinoma.
Scope
This area orients the reader to the specimen types and analytic logic of urinary cytology: how specimens are collected and prepared, how adequacy is judged, how urothelial carcinoma and its variants present cytologically, how benign and inflammatory mimics are recognised, how standardised reporting systems express diagnostic certainty, and how cytology of the upper urinary tract differs from bladder sampling. It is a reference and educational overview, not clinical guidance.
Sub-topics
Core questions
- How are urinary specimens collected, prepared, and judged adequate for evaluation?
- Which cytomorphologic features reliably distinguish high-grade urothelial carcinoma from benign mimics?
- How do standardised reporting systems translate cellular findings into diagnostic categories and risk of malignancy?
- How does cytology of the upper urinary tract differ from cytology of the bladder?
Key concepts
- Exfoliative and instrumented urinary specimens
- Specimen adequacy
- High-grade urothelial carcinoma detection
- Atypical urothelial cells
- Standardised reporting (The Paris System)
- Ancillary testing (FISH, immunostains)
- Upper-tract versus lower-tract sampling
Mechanisms
Urothelial cells exfoliate spontaneously into urine and can also be dislodged by washing, catheterisation, or brushing. High-grade malignant cells tend to shed readily and display nuclear features — high nuclear-to-cytoplasmic ratio, hyperchromasia, and irregular nuclear membranes — that are detectable even in small numbers, which underlies cytology's strength for high-grade disease. Low-grade lesions exfoliate cohesive, bland cells that overlap with normal and reactive urothelium, which limits cytologic detection. Reporting systems formalise these observations into reproducible categories, and ancillary molecular tests such as fluorescence in situ hybridisation can supplement morphology in equivocal cases (kurtycz-2020; lee-2015).
Clinical relevance
Urine cytology is a non-invasive adjunct used alongside cystoscopy in the evaluation and surveillance of urothelial carcinoma; it is valued for high specificity and sensitivity for high-grade disease, and these properties describe how the test contributes to evidence rather than dictating individual management. The information here is educational and is not a basis for diagnostic or treatment decisions.
Epidemiology
Urothelial carcinoma of the bladder is among the more common urinary tract malignancies, and the great majority of clinically significant urinary cytology workload concerns its detection and surveillance. Meta-analytic estimates of the risk of malignancy associated with each standardised diagnostic category provide the quantitative backbone for interpreting urinary cytology reports (nikas-2022).
Evidence & guidelines
The dominant framework in contemporary practice is The Paris System for Reporting Urinary Cytology, first published in 2016 and revised as a second edition in 2022, which standardises terminology, adequacy criteria, and diagnostic categories anchored on the detection of high-grade urothelial carcinoma. Meta-analyses summarise the risk of malignancy for each category (kurtycz-2020; nikas-2022; pambuccian-2022-history).
History
Urinary cytology dates to nineteenth-century descriptions of malignant cells in urine and matured through the twentieth century alongside Papanicolaou's exfoliative methods. Persistent variability in terminology motivated the international development of The Paris System, which reframed the discipline around the reliable detection of high-grade urothelial carcinoma (pambuccian-2022-history).
Debates
- How should the atypical urothelial cell category be defined and minimised?
- The 'atypical urothelial cells' category carries an intermediate, variably reported risk of malignancy, and balancing its sensitivity against overuse remains an active subject of refinement across editions of standardised reporting.
Key figures
- Dorothy Rosenthal
- Eva Wojcik
- Christopher VandenBussche
- Güliz Barkan
- Daniel Kurtycz
Related topics
Seminal works
- kurtycz-2020
- nikas-2022
- pambuccian-2022-history
Frequently asked questions
- What is urine cytology best at detecting?
- It is most reliable for high-grade urothelial carcinoma, whose cells exfoliate readily and show distinctive nuclear changes; it is much less sensitive for low-grade lesions, whose cells closely resemble benign urothelium.
- What specimen types are used in urinary cytopathology?
- Voided urine, bladder washings or barbotage, catheterised urine, and brushings of the ureter or renal pelvis, each with different cellularity and interpretive considerations.